In Kids with Crohn's Disease, TNF Inhibitors Help Prevent Serious Complications, Data Suggests

Follow Drugslib on

Medically reviewed by Drugs.com.

By Dennis Thompson HealthDay Reporter

FRIDAY, Dec. 27, 2024 A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn’s disease.

A new study published recently in the journal Gut shows children with Crohn's who were prescribed anti-TNF (tumor necrosis factor) drugs following their diagnosis had an 82% lower risk of anal fistulas, or tunnels that develop from inside the anus to the skin outside.

These tunnels appear as open draining sores near the anus, and increase a child’s risk of infections or organ damage, researchers said.

About 70% of kids who develop an anal fistula require at least one surgical procedure, researchers said. This frequently involves fitting the child with a colostomy bag.

“If we can prevent these disease complications, that’s way better than trying to address them once they develop, because they’re so hard to treat,” lead researcher Dr. Jeremy Adler, a clinical professor of pediatric gastroenterology with the University of Michigan, said in a news release.

About 40,000 children in the U.S. suffer from Crohn’s disease, a chronic inflammatory disease of the gut that causes diarrhea, cramping and pain.

Of those children, about one in three will develop anal fistulas, researchers said.

For the study, researchers tracked more than 900 children newly diagnosed with Crohn’s.

They found that prescribing anti-TNF drugs like infliximab and adalimumab from the outset significantly decreased a child’s risk of anal fistulas. These drugs block TNF, a substance that causes inflammation.

This was particularly true for children who had already developed large skin tags, ulcers or fissures near their anus. The presence of these lesions quadruples a child’s odds of anal fissures, study results show.

But for those kids, anti-TNF drugs decreased their risk of anal fistulas by 93%, researchers found.

Anti-TNF drugs are pricier than other anti-inflammatory drugs used to treat Crohn’s like azathioprine and methotrexate, researchers said.

However, these results show that anti-TNF drugs might be worth the added cost, if they can help kids avoid anal fistulas that are even more expensive to treat, Adler said.

“For the insurance companies, you prevent the fistulas and all the downstream complications those cost,” Adler said. “For the physician, it shows this is really the more efficacious treatment.”

“For the families, it’s a question of which drug. And this group of medicines is so effective at preventing complications," Adler concluded.

Sources

  • University of Michigan, news release, Dec. 27, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-12-28 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords